The spin-out of Shimane University puts a focus on rapidly expanding cells (REC) stem cells from human bone marrow which constitute 0.001 % or less of mesenchymal cells. It is anticipated that REC cells can differentiate into self-proliferating cells which can be used for the treatment of, e. g., autoimmun diseases.

Shimane University news release, January 29, 2016